Description
| What It Is | TB-500 is a synthetic 43–amino–acid peptide corresponding to the thymosin beta-4 (Tβ4) sequence motif and studied in laboratory research as an actin-binding peptide involved in cytoskeletal biology. |
| What It’s Derived From | TB-500 is derived from the endogenous thymosin beta-4 protein, a widely distributed actin-binding molecule. It represents a synthetic analogue used to investigate actin monomer (G-actin) sequestration and actin filament (F-actin) dynamics in experimental systems. |
| What Research Focuses On | Research evaluates TB-500 in in vitro and preclinical models examining cytoskeletal remodeling, cell migration dynamics, extracellular matrix (ECM) reorganization, angiogenesis-associated transcriptional programs, oxidative stress signaling, epithelial and stromal re-epithelialization kinetics, and tissue-remodeling endpoints under controlled laboratory conditions. |





Reviews
There are no reviews yet.